Dupuytren Contracture

Pronounced: du-pwe-trahn kon-trak-choor


Dupuytren contracture is a thickening and tightening of the tissue in the palm and fingers. It causes one or more fingers to be curled in toward the palm.

Dupuytren Contracture Scarring

Nucleus factsheet image
Copyright © Nucleus Medical Media, Inc.


The exact cause is not known. It may be due to genetics and the environment.

Risk Factors

It is more common in people of Northern European descent. It is also more common in men and people over 40 years old. Other things that may raise the risk are:


The main problem is not being able to straighten the finger. The ring finger is usually affected first. The pinky finger is often second. The index and long finger may follow. This does not cause pain in most people. Other problems may be:

  • A bump in the palm near the bottom of a finger
  • Skin on the palm that looks pitted, thick, or dimpled
  • Loss of grip strength


The doctor will ask about your symptoms and health history. A hand exam will be done.


There is no cure. Treatment may not be needed in people who are still able to use their fingers. Other people may need:


Medicine may be injected into the area. It may be:

  • Corticosteroids to slow the disease and ease pain and swelling
  • Collagenase clostridium histolyticum to break down the thickened tissue


Some people may need surgery when initial care does not help or the problem is severe. Surgery may break up or remove the thickened tissue. This may help straighten the finger and help it to move. The problem may come back and surgery may need to be repeated.

A splint will need to be worn after surgery. Exercises will also need to help with strength and movement.


There are no known methods to prevent Dupuytren contracture.


American Society for Surgery of the Hand
Family Doctor—American Academy of Family Physicians


Canadian Centre for Occupational Health and Safety


Badalamente MA, Hurst LC, et al. Efficacy and safety of collagenase Clostridium Histolyticum in the treatment of proximal interphalangeal joints in Dupuytren contracture: Combined analysis of 4 phase 3 clinical trials. J Hand Surg. 2015;5:975-983.
Degreef I, Tejpar S, et al. High-dosage Tamoxifen as neo adjuvant treatment in minimally invasive surgery for Dupuytren Disease in patients with strong pre disposition toward fibrosis. J Bone Joint Surg Am. 2014;96(8):655-662.
Dupuytren disease. EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/dupuytren-disease. Updated February 8, 2017. Accessed September 7, 2017.
Lanting R, Broekstra DC, Werker PMN, van den Heuvel ER. A systematic review and meta-analysis on the prevalence of Dupuytren Disease in the general population of Western countries. Plast Reconstr Surg. 2014;133(3):593-603.
Riester S, vanWijnen A, Rizzo M, Kakar S. Pathogenesis and treatment of Dupuytren disease. J Bone Joint Surg Reviews. 2014;2(4):e2.
Last reviewed September 2019 by EBSCO Medical Review Board Teresa Briedwell, PT, DPT, OCS, CSCS
Last Updated: 8/19/2020

EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days.